Harry Kay

Fundamental Investing. Early $PLTR, $HIMS, $UPST, $FIG & $RBRK.

[Harry Kay @HarryKay_]

Upstart is my most contrarian position to date.

I've never come across a more misunderstood company, with a deeper asymmetry, than $UPST.

And this is coming from an early Palantir $PLTR and Rocket Lab $RKLB investor!

Stay tuned for my debut article - follow and subscribe to my Substack!

-> https://t.co/QRa3m1qCKS

[Harry Kay @HarryKay_]

@tyler_bosserman @CMDarnton0 👀👀

[Harry Kay @HarryKay_]

@MagnusSigurdss @HenryInvests @goddreng10 We’ll have to see.

Initially I thought the same but unsure.

[Henry @HenryInvests]

@HarryKay_ @MagnusSigurdss @goddreng10 Agree, #UTPI is undeniably a leading indicator - it highlighted the model tightening in 3Q25 prior to ER. But the direct relationship is not 1:1, and is evolving quickly due to loan mix, etc. So I agree - it's directionally right, but not all encompassing

[Harry Kay @HarryKay_]

I think it can be interpreted to be directionally correct; it’s impossible to be exactly right.

We also have no idea how the flux in the mix of loans is altering, among other variables.

It’s the best we have but I take a conservative, directionally-focused view, on Parth’s work.

[Harry Kay @HarryKay_]

Fantastic coup from @HenryInvests!

CFO of Upstart! Well done

[Henry @HenryInvests]

📅 Mark Your Calendars!

Friday, June 12th • 8:30 AM PT / 11:30 AM ET • I'll sit down with @Upstart $UPST CFO Andrea Blankmeyer LIVE 🚨

Have a question you'd like to ask Andrea? Drop it below and I'll bring the best to the stage 🎙️

Watch live right here on X @HenryInvests or @Rebellionaire (X & YouTube) 🦁🦁

[Harry Kay @HarryKay_]

Great work once again- June originations will be telling.

[Henry @HenryInvests]

Upstart $UPST May Trustpilot #UTPI reviews hit 1,343, up 64.4% YoY and 19.5% MoM🛡️⚔️

May's Trustpilot Reviews per Day hit 43.3, up 64.4% YoY and 15.6% MoM, reaching a new all-time high. This comes in light of April UMI reaching 1.46, the highest level since August '26.

Upstart will publish May origination data this Wednesday (June 3), which will reconcile the relationship between Trustpilot reviews and Originations.

[Harry Kay @HarryKay_]

This can never be part of a thesis and certainly isn’t factored into mine - but Upstart is unbelievably cheap right now and it’s starting to be recognised 👀

$UPST

https://t.co/eavuwIsJOg

[Harry Kay @HarryKay_]

“Not dead”

[Dylan Field @zoink]

Quick update: not dead.

$FIG Q1 results:

→ 46% YoY revenue growth, accelerating for the 2nd straight quarter
→ Net Dollar Retention Rate increased to 139%, our highest rate in over two years
→ Raising 2026 revenue guidance for the year

Design matters more than ever.

[Harry Kay @HarryKay_]

Appears I virtually timed the bottom on Figma - suspect it will never reach these levels again…

Modest position at $17.30

Incredible earnings.

$FIG

[Harry Kay @HarryKay_]

give me another year of Upstart under $30!

please! I'm begging you!

$UPST

[Harry Kay @HarryKay_]

There we go Upstart shareholders.

The man has spoken.

$UPST

[Dave Girouard @davegirouard]

$UPST

[Harry Kay @HarryKay_]

Upstart is a company you NEVER sell

[Paul H @PaulH555777]

@HarryKay_ Lol this idiot knows how to burn money. He'll flip it at 34

[Harry Kay @HarryKay_]

This is exactly why I have no worries re operating expenses and balance sheet…

They’re backing what they know; not fleeing the ship.

It’s not often you see management purchase shares of any public company these days - massive news

$UPST

[Henry @HenryInvests]

🚨

@davegirouard bought $5M of $UPST
@paulxgu bought $3.9M of $UPST

Let's GO! 😎

[Harry Kay @HarryKay_]

Just in: Dave Girouard purchases $5m of Upstart shares!

$UPST

[Harry Kay @HarryKay_]

Really great set of results for Omada - another company I’m keenly following.

Big fan of the CEO Sean Duffy a born founder: spotted a problem, fixed it himself.

$OMDA

[Sean Duffy @seanduffy]

@OmadaHealth just reported a milestone Q1 2026 💪

Very proud of the team for:
💡 1M+ Total Members, a first in our history
💡 Revenue +42% YoY to $78M
💡 GAAP net loss narrowed to $3M; positive Adjusted EBITDA (non-GAAP) in our highest-cost quarter
💡 Margins expanded; full-year guidance raised

Our business runs on four growth levers: expanding reach, increasing enrollment, deepening engagement, and operational efficiency. We delivered against each in Q1.

We believe our new offerings with Optum Rx and Lilly's Employer Connect will help catalyze our mission.

Grateful, proud, and more motivated than ever to keep bending the curve of chronic disease.

$OMDA https://t.co/0h2BSlPtzA

[Harry Kay @HarryKay_]

I think this is more so the core anxiety of most $UPST investors at the moment: the opportunity cost given the entire AI hardware space is ballooning in the mean time.

Personally, I'm quite settled, but it depends what kind of investor you are. I never entered Upstart for short/medium term gains, though I appreciate many have been invested for a lot longer than me too!

Time will tell.

[Harry Kay @HarryKay_]

guys it's not like @paulxgu bought $3.9m of Upstart in November or anything and now has ultimate control of the destiny of the company or anything...

$UPST

[Harry Kay @HarryKay_]

Hims bull thesis unlocked 🔓

https://t.co/kAAjZF68mD